Clinical Trials Browser

Phase 2 × Triple Negative Breast Neoplasms × anlotinib × Clear all

NCT04914390 2024-01-22

NeoATCT

Phase 2 Unknown

Triple Negative Breast Neoplasms

NCT05089643 2022-01-10

Anrotinib in Combination With Capecitabine in Advanced Triple Negative Breast Cancer

Phase 2 Unknown

Triple Negative Breast Neoplasms

NCT04452370 2021-07-21

Oral Etoposide Combined With Anlotinib in Advanced Triple Negative Breast Cancer

Phase 2 Unknown

Triple Negative Breast Neoplasms